✦ LIBER ✦

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

✍ Scribed by Hussein Sadek; Nacer Azli; Jean Louis Wendling; Esteban Cvitkovic; Mohamed Rahal; Gerard Mamelle; Jean Claude Guillaume; Jean Pierre Armand; Marie France Avril

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 455 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19901015)66:8<1692::aid-cncr2820660807>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and 5-fluorouracil for advance

Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin

✍ Tawfiq Khansur; Alan Kennedy 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

Seven patients with advanced locoregional or metastatic squamous cell carcinoma of the skin were treated with cis-daimminedichloroplatin (cisplatin) and 5fluorouracil(5-FU). Responses were seen in six of seven patients (three partial responses [PR] and three complete responses [CR]). One patient is

Cisplatin and 5-fluorouracil chemotherap

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

✍ Richard J. Mercier; G. David Neal; Douglas E. Mattox; George A. Gates; Thomas C. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Paclitaxel, 5-fluorouracil, and cisplati

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

✍ Yeul H. Kim; Sang W. Shin; Byung S. Kim; Jin H. Kim; Jong G. Kim; Young J. Mok; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy

Cisplatin and doxorubicin. An effective

Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin

✍ Troy H. Guthrie Jr.; Leland J. McElveen; Edward S. Porubsky; John D. Harmon 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Sequential methotrexate–5-fluorouracil t

Sequential methotrexate–5-fluorouracil treatment of squamous cell carcinoma of the head and neck

✍ Ulrik Ringborg; GÖSta Ewert; Jan Kinnman; Per-Gotthard Lundqvist; Hans Strander 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 2 views

Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue. The frequency of objective tumor regression obtained was 64% (complete response + partial response) with 19% complete regression. In 20 not pr